These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7666381)

  • 1. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
    Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY
    J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
    Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
    J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
    Maes M; Meltzer HY; Bosmans E
    Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
    Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
    J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia.
    Müller N; Empl M; Riedel M; Schwarz M; Ackenheil M
    Eur Arch Psychiatry Clin Neurosci; 1997; 247(6):308-13. PubMed ID: 9477010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs.
    Maes M; Goossens F; Scharpé S; Calabrese J; Desnyder R; Meltzer HY
    Psychiatry Res; 1995 Oct; 58(3):217-25. PubMed ID: 8570777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
    Maes M; Meltzer HY; Buckley P; Bosmans E
    Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo immunomodulatory effects of clozapine in schizophrenia.
    Maes M; Bosmans E; Kenis G; De Jong R; Smith RS; Meltzer HY
    Schizophr Res; 1997 Aug; 26(2-3):221-5. PubMed ID: 9323354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs.
    Maes M; Bosmans E; Ranjan R; Vandoolaeghe E; Meltzer HY; De Ley M; Berghmans R; Stans G; Desnyder R
    Schizophr Res; 1996 Jul; 21(1):39-50. PubMed ID: 8998275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of plasma IL-6 and soluble IL-6 receptor levels with the Asp358Ala polymorphism of the IL-6 receptor gene in schizophrenic patients.
    Sasayama D; Wakabayashi C; Hori H; Teraishi T; Hattori K; Ota M; Ishikawa M; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2011 Nov; 45(11):1439-44. PubMed ID: 21700295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of indices of cell-mediated immunity in bipolar mania.
    Tsai SY; Chen KP; Yang YY; Chen CC; Lee JC; Singh VK; Leu SJ
    Biol Psychiatry; 1999 Apr; 45(8):989-94. PubMed ID: 10386181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
    Maes M; Meltzer HY; Bosmans E
    Neuropsychobiology; 1994; 30(2-3):57-60. PubMed ID: 7800164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.
    Lin A; Kenis G; Bignotti S; Tura GJ; De Jong R; Bosmans E; Pioli R; Altamura C; Scharpé S; Maes M
    Schizophr Res; 1998 Jun; 32(1):9-15. PubMed ID: 9690329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics.
    Maes M; Bocchio Chiavetto L; Bignotti S; Battisa Tura G; Pioli R; Boin F; Kenis G; Bosmans E; de Jongh R; Lin A; Racagni G; Altamura CA
    Eur Neuropsychopharmacol; 2000 Mar; 10(2):119-24. PubMed ID: 10706993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC
    J Clin Psychiatry; 2004 Jul; 65(7):940-7. PubMed ID: 15291683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor.
    Maes M; Bocchio Chiavetto L; Bignotti S; Battisa Tura GJ; Pioli R; Boin F; Kenis G; Bosmans E; de Jongh R; Altamura CA
    Schizophr Res; 2002 Apr; 54(3):281-91. PubMed ID: 11950553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia.
    Rapaport MH; Lohr JB
    Acta Psychiatr Scand; 1994 Nov; 90(5):311-5. PubMed ID: 7872033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
    Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
    Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.